On the Front Lines of Hope: Dr. Mitchell Cairo’s Mission to Cure Childhood Cancer
Even on the most taxing days, Dr. Cairo draws resolve from looking back on the strides made in his field. “To put it in perspective, when I started practicing in the early 1980s, only 20 percent of children with cancer survived,” says Dr. Cairo. “For every five patients I diagnosed, I attended four funerals. Today, the cure rate is rapidly approaching 85 percent. We have had a great renaissance over the last 50 years, and we are on the brink of developing therapy that’s even more well-tolerated.”
The Children's Cancer Fund is a nonprofit committed to supporting the fight against Pediatric Cancer and Blood Diseases.
By supporting the clinical and research programs at Maria Fareri Children's Hospital and New York Medical College, we impact their ability to provide state of the art, quality care for children and adolescents right here in our Westchester community.
Spotlight Campaign
Donations to the Children's Cancer Fund of NY in memory of Mikha
Mikha was a loving friend, colleague, and husband. He left his mark on the world through his kind-hearted nature and genuinity. He was not the loudest in the room, but his presence was always felt by those around him. Funny, collected, and intelligent are just a few words to describe Mikha. From writing a novel about his life in Africa to moving to New York, he truly experienced the world and lived life to the fullest.
Not only was Mikha pursuing a career in law, but he was also a dedicated member of Liberty’s team. His drive, ambition, and insight were deeply valued by all who worked alongside him. His legacy will live on and he will continue to be remembered by those who have had the pleasure of knowing him. Mikha is forever in our hearts.
We invite you to celebrate Mikah’s legacy by making a gift that touches the lives of children who bravely battle cancer as he did.
The Helping Osteosarcoma Patients Everywhere (HOPE) Super Grant
A $1.5 million research project which began on October 1, 2023, is led by Dr. Mitchell Cairo at New York Medical College. The goal of the grant is to develop novel combinatorial immunotherapy that will significantly increase the overall survival in children and adolescents with relapsed osteosarcoma.
Courageous Chronicles: Patient Stories
Uplifting Stories of Resilience & Journeys from the Lives of Our Remarkable Patients
Join Our Newsletter
Sign up to stay connected, learn about upcoming events & more ways to contribute.